Life Technologies buys Advanced Microscopy Group; EU awards $7.6M for preeclampsia Dx consortium;

 @FierceMedDev: Some regulatory decisions on devices and drugs may face delays. Blame Hurricane Sandy. More | Follow @FierceMedDev

 @MarkHFierce: More woes for Abiomed. Shareholders will now investigate the company's marketing and labeling of its Impella 2.5. More | Follow @MarkHFierce

 @DamianFierce: The Indian clinical trial industry will continue to explode, but only if it cleans up its act, TOI says. More | Follow @DamianFierce

> X-spine gained FDA clearance for two of its spinal implant systems. Item

> Drexel University researchers have come up with a near infrared device designed to help locate bedsores in patients before they appear on the skin. Story

> The European Union will give out more than $7.6 million in research funding to a consortium working to develop a predictive diagnostic test for preeclampsia. Release

> The FDA is blaming the massive storm Sandy for likely delays in the coming weeks for medical device, biosimilar and prescription drug approvals. Story

> Scientists at Belgium's Vrije Universiteit Brussel have developed a prosthetic foot that mimics the way a human ankle springs. Item

> Life Technologies ($LIFE) has snatched up Advanced Microscopy Group, a developer of imaging systems for research microscopy. Release

> Brigham Young University scientists have come up with a low-cost device that will allow for inexpensive testing of diseases. Story

Biotech News

 @FierceBiotech: Merck finds pharma research results with online competition. More | Follow @FierceBiotech

 @JohnCFierce: BioMarin shares pop on strong pivotal data for rare disease drug. More | Follow @JohnCFierce

 @RyanMFierce: Winners named in Merck's online competition involving pharma research, Kaggle blog. More | Follow @RyanMFierce

> Ex-Pfizer crew snags $27M financing for U.K. drugs startup. News

> Experts rip chelation heart study despite a hint of efficacy. Article

Pharma News

@FiercePharma: FDA backs Boehringer Ingelheim's Pradaxa on safety. Big caution, though, in bold type: Use as directed. More | Follow @FiercePharma

> Sanofi brass considered pulling home base out of France. Article

> Drugmakers offer Greece option to end bad debt spiral. News

> India strips patent from Roche's hep C drug Pegasys. Story

Biotech IT News

> Roche seeks advances in cloud computing for cancer drug research. News

> Sanofi deal bolsters Medidata in record quarter for revenue. Article

> Titan slays Jaguar in computing comparison, open to R&D comers. Report

>Merck finds pharma research results with online competition. Story

CRO News

> Quintiles chief: CROs need to jump on sequencing bandwagon. Item

> GE pours $23M into Biocon's CRO as it plots public offering. Story

> Icon soars in Q3, plots Nasdaq jump. Report

> Cyprotex snags deal with Pfizer for toxicology. More

> Charles River pays $27M for majority of Chinese company. News

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.